Colon Carcinoma clinical trials

Explore recruiting colon carcinoma clinical trials.

Recruiting colon carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Colon Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PRODIGE 87 FOXTROT II : Personalising and refining neo-adjuvant chemotherapy in locally advanced but resectable colon cancer in the elderly of 70 years old or more

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

PRODIGE 88-CIRCULATE PAC: Phase III multicentric, open-label, randomized study to investigate the efficacy of chemotherapy in patients with positive ctDNA after surgery and adjuvant chemotherapy for a high-risk stage II and stage III Colorectal Cancer

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

PRODIGE 70 - CIRCULATE - CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Double-blind, randomized, placebo-controlled, study to evaluate the safety and efficacy of HRX215 in participants after major hepatectomy, preceded by two open pilot parts in participants after minor and after major hepatectomy due to colon carcinoma metastases

France, Spain, Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients.

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Colon Carcinoma trials by city

Colon Carcinoma in Toronto Colon Carcinoma in Vancouver Colon Carcinoma in Montreal Colon Carcinoma in Calgary Colon Carcinoma in Edmonton Colon Carcinoma in Ottawa Colon Carcinoma in Winnipeg Colon Carcinoma in Quebec City Colon Carcinoma in Hamilton Colon Carcinoma in Kitchener Colon Carcinoma in London Colon Carcinoma in Halifax Colon Carcinoma in New York Colon Carcinoma in Los Angeles Colon Carcinoma in Chicago Colon Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease